Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,886 public trials 2,115 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

NCT00326898

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
View all 987 locations
View Trial Details
Completed

A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma

NCT03294083

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Site 2644 University of California, Irvine Irvine, California, United States
  • Site 2641 University of Miami Miami, Florida, United States
  • Site 2643 Washington University St Louis, Missouri, United States
  • Site 2642 Billings Clinic Billings, Montana, United States
View all 21 locations
View Trial Details
Completed

A Study to Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

NCT05867121

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +20 more
Locations
  • UCLA University of California Los Angeles Los Angeles, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • St Vincent'S Hospital Darlinghurst, New South Wales, Australia
View all 27 locations
View Trial Details
Completed

A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

NCT04102098

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • Kaiser Permanente Los Angeles Los Angeles, California, United States
  • Mercy Medical Center Baltimore, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Columbia University Medical Center New York, United States
View all 134 locations
View Trial Details

Related conditions